作为强效抗菌靶标的新型四唑基-1,2,3-三唑衍生物:设计、合成和分子对接技术。

IF 2.7 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Kumaraswamy Sadineni, Sharath Babu Haridasyam, Venkanna Gujja, Venkatanaryana Muvvala, Sunil Kumar Nechipadappu, Kishore Veera Venkata Nanda Pilli, Kalyani Chepuri, Tejeswara Rao Allaka
{"title":"作为强效抗菌靶标的新型四唑基-1,2,3-三唑衍生物:设计、合成和分子对接技术。","authors":"Kumaraswamy Sadineni, Sharath Babu Haridasyam, Venkanna Gujja, Venkatanaryana Muvvala, Sunil Kumar Nechipadappu, Kishore Veera Venkata Nanda Pilli, Kalyani Chepuri, Tejeswara Rao Allaka","doi":"10.1080/07391102.2024.2425830","DOIUrl":null,"url":null,"abstract":"<p><p>The main objective of this study is to produce novel triazoles-loaded tetrazoles, which are crucial in the development of prospective therapeutic agents in medicinal chemistry. Recent investigations have found a wide range of uses for these derivatives, and they are prospective lead molecules for the synthesis of substances with enormous therapeutic utility for various diseases, especially for bacterial therapy. New series of 1,2,3-triazole derivatives have been synthesized from methyl (2S,4S)-4-azido-1-(2,4-difluoro-3-methylbenzoyl)pyrrolidine-2-carboxylate (<b>5</b>) using a well-established click reaction that has several advantages to afford a novel heterocyclic compound based on tetrazole moieties. The structures of the new compounds were ascertained by spectral means (IR, NMR: <sup>1</sup>H and <sup>13</sup>C) and mass spectrum. All the synthesized compounds were assessed <i>in vitro</i> antimicrobial activity against Gram-+ve (<i>S. pyogenes</i>, <i>S. aureus</i> and <i>B. subtilis</i>), Gram-negative (<i>E. coli</i> and <i>P. aeruginosa</i>) bacterial and fungal strains <i>A. flavus</i> and <i>C. albicans</i>. The prepared compounds <b>7b</b> and<b>7f</b> proved to have strong impact on <i>S. aureus</i> and <i>S. pyogenes</i> strains with MICs of 2.5 µg/mL and 1.5 µg/mL respectively. Among the tested compounds, hybrids <b>7b</b>, <b>7f</b>, <b>7h</b>, and <b>7i</b> exhibited exceptional antifungal susceptibilities against <i>C. albicans</i> with zone of inhibition 25 ± 0.2, 30 ± 0.3, 30 ± 0.1, and 28 ± 0.2 mm respectively, which is stronger than fluconazole (28 ± 0.1 mm). The capacity of ligand <b>7f</b> to form a stable compound on the active site of <i>S. aureus</i> complex with DNA Gyrase (2XCT) was confirmed by docking studies using amino acids Ala233(A), Arg234(A), Gly283(A), Ser286(A), Lys52(A), His280(A), Gly51(A), His282(A) and Val246(A). Furthermore, the physicochemical and ADME (absorption, distribution, metabolism, and excretion) filtration molecular properties, estimation of toxicity, and bioactivity scores of these scaffolds were evaluated.</p>","PeriodicalId":15272,"journal":{"name":"Journal of Biomolecular Structure & Dynamics","volume":" ","pages":"1-16"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Novel tetrazolyl-1,2,3-triazole derivatives as potent antimicrobial targets: design, synthesis and molecular docking techniques.\",\"authors\":\"Kumaraswamy Sadineni, Sharath Babu Haridasyam, Venkanna Gujja, Venkatanaryana Muvvala, Sunil Kumar Nechipadappu, Kishore Veera Venkata Nanda Pilli, Kalyani Chepuri, Tejeswara Rao Allaka\",\"doi\":\"10.1080/07391102.2024.2425830\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The main objective of this study is to produce novel triazoles-loaded tetrazoles, which are crucial in the development of prospective therapeutic agents in medicinal chemistry. Recent investigations have found a wide range of uses for these derivatives, and they are prospective lead molecules for the synthesis of substances with enormous therapeutic utility for various diseases, especially for bacterial therapy. New series of 1,2,3-triazole derivatives have been synthesized from methyl (2S,4S)-4-azido-1-(2,4-difluoro-3-methylbenzoyl)pyrrolidine-2-carboxylate (<b>5</b>) using a well-established click reaction that has several advantages to afford a novel heterocyclic compound based on tetrazole moieties. The structures of the new compounds were ascertained by spectral means (IR, NMR: <sup>1</sup>H and <sup>13</sup>C) and mass spectrum. All the synthesized compounds were assessed <i>in vitro</i> antimicrobial activity against Gram-+ve (<i>S. pyogenes</i>, <i>S. aureus</i> and <i>B. subtilis</i>), Gram-negative (<i>E. coli</i> and <i>P. aeruginosa</i>) bacterial and fungal strains <i>A. flavus</i> and <i>C. albicans</i>. The prepared compounds <b>7b</b> and<b>7f</b> proved to have strong impact on <i>S. aureus</i> and <i>S. pyogenes</i> strains with MICs of 2.5 µg/mL and 1.5 µg/mL respectively. Among the tested compounds, hybrids <b>7b</b>, <b>7f</b>, <b>7h</b>, and <b>7i</b> exhibited exceptional antifungal susceptibilities against <i>C. albicans</i> with zone of inhibition 25 ± 0.2, 30 ± 0.3, 30 ± 0.1, and 28 ± 0.2 mm respectively, which is stronger than fluconazole (28 ± 0.1 mm). The capacity of ligand <b>7f</b> to form a stable compound on the active site of <i>S. aureus</i> complex with DNA Gyrase (2XCT) was confirmed by docking studies using amino acids Ala233(A), Arg234(A), Gly283(A), Ser286(A), Lys52(A), His280(A), Gly51(A), His282(A) and Val246(A). Furthermore, the physicochemical and ADME (absorption, distribution, metabolism, and excretion) filtration molecular properties, estimation of toxicity, and bioactivity scores of these scaffolds were evaluated.</p>\",\"PeriodicalId\":15272,\"journal\":{\"name\":\"Journal of Biomolecular Structure & Dynamics\",\"volume\":\" \",\"pages\":\"1-16\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biomolecular Structure & Dynamics\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1080/07391102.2024.2425830\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomolecular Structure & Dynamics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/07391102.2024.2425830","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本研究的主要目的是制备新型三唑负载四唑,这对开发药物化学领域的前瞻性治疗药物至关重要。最近的研究发现了这些衍生物的广泛用途,它们是合成对各种疾病,尤其是细菌疗法有巨大治疗作用的物质的前导分子。我们采用一种具有多种优点的成熟点击反应,从 (2S,4S)-4-叠氮-1-(2,4-二氟-3-甲基苯甲酰基)吡咯烷-2-甲酸甲酯 (5) 合成了一系列新的 1,2,3-三唑衍生物,从而得到了一种基于四唑分子的新型杂环化合物。通过光谱(红外光谱、核磁共振:1H 和 13C)和质谱确定了新化合物的结构。对所有合成化合物进行了体外抗菌活性评估,包括针对革兰氏阳性(化脓性链球菌、金黄色葡萄球菌和枯草杆菌)、革兰氏阴性(大肠杆菌和绿脓杆菌)细菌和真菌菌株黄曲霉和白僵菌的抗菌活性。制备的化合物 7b 和 7f 被证明对金黄色葡萄球菌和化脓性葡萄球菌有很强的抑制作用,其 MICs 分别为 2.5 µg/mL 和 1.5 µg/mL。在测试的化合物中,杂交化合物 7b、7f、7h 和 7i 对白僵菌的抗真菌敏感性极高,抑制区分别为 25 ± 0.2、30 ± 0.3、30 ± 0.1 和 28 ± 0.2 mm,强于氟康唑(28 ± 0.1 mm)。通过使用氨基酸 Ala233(A)、Arg234(A)、Gly283(A)、Ser286(A)、Lys52(A)、His280(A)、Gly51(A)、His282(A)和 Val246(A)进行对接研究,证实了配体 7f 在金黄色葡萄球菌与 DNA 回旋酶(2XCT)复合物的活性位点上形成稳定化合物的能力。此外,还评估了这些支架的理化和 ADME(吸收、分布、代谢和排泄)过滤分子特性、毒性估计和生物活性评分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Novel tetrazolyl-1,2,3-triazole derivatives as potent antimicrobial targets: design, synthesis and molecular docking techniques.

The main objective of this study is to produce novel triazoles-loaded tetrazoles, which are crucial in the development of prospective therapeutic agents in medicinal chemistry. Recent investigations have found a wide range of uses for these derivatives, and they are prospective lead molecules for the synthesis of substances with enormous therapeutic utility for various diseases, especially for bacterial therapy. New series of 1,2,3-triazole derivatives have been synthesized from methyl (2S,4S)-4-azido-1-(2,4-difluoro-3-methylbenzoyl)pyrrolidine-2-carboxylate (5) using a well-established click reaction that has several advantages to afford a novel heterocyclic compound based on tetrazole moieties. The structures of the new compounds were ascertained by spectral means (IR, NMR: 1H and 13C) and mass spectrum. All the synthesized compounds were assessed in vitro antimicrobial activity against Gram-+ve (S. pyogenes, S. aureus and B. subtilis), Gram-negative (E. coli and P. aeruginosa) bacterial and fungal strains A. flavus and C. albicans. The prepared compounds 7b and7f proved to have strong impact on S. aureus and S. pyogenes strains with MICs of 2.5 µg/mL and 1.5 µg/mL respectively. Among the tested compounds, hybrids 7b, 7f, 7h, and 7i exhibited exceptional antifungal susceptibilities against C. albicans with zone of inhibition 25 ± 0.2, 30 ± 0.3, 30 ± 0.1, and 28 ± 0.2 mm respectively, which is stronger than fluconazole (28 ± 0.1 mm). The capacity of ligand 7f to form a stable compound on the active site of S. aureus complex with DNA Gyrase (2XCT) was confirmed by docking studies using amino acids Ala233(A), Arg234(A), Gly283(A), Ser286(A), Lys52(A), His280(A), Gly51(A), His282(A) and Val246(A). Furthermore, the physicochemical and ADME (absorption, distribution, metabolism, and excretion) filtration molecular properties, estimation of toxicity, and bioactivity scores of these scaffolds were evaluated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Biomolecular Structure & Dynamics
Journal of Biomolecular Structure & Dynamics 生物-生化与分子生物学
CiteScore
8.90
自引率
9.10%
发文量
597
审稿时长
2 months
期刊介绍: The Journal of Biomolecular Structure and Dynamics welcomes manuscripts on biological structure, dynamics, interactions and expression. The Journal is one of the leading publications in high end computational science, atomic structural biology, bioinformatics, virtual drug design, genomics and biological networks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信